发明名称 PRODUCTION OF SPHINGOLIPID
摘要 PROBLEM TO BE SOLVED: To simply produce the subject compound which is useful in the treatment of cancers, rheumatoid arthritis, diabetes complication, central nervous system disorder by culturing a proper microorganism, for example, Oomycetes, collecting its mycelia and isolating the objective sphingolipid from the mycelia. SOLUTION: A microorganism in Oomycetes, for example, Pythium ultimum (ATCC 26083) is inoculated into a culture medium, subjected to the shaking culture at 25 deg.C for 48 hours. Then, the mycelia are collected by filtration on a glass fiber filter, rinsed with water and freeze-dried. The cells of the freeze- dried mycelia are charged in screw tubes containing chloroform, methanol and water, they are homogenized by means of a homogenizer for 30 seconds, then chloroform and water are added to the homogenized product to cause a phase separation. The lower chloroform phase is recovered and subjected to a semi-preparative HPL chromatography whereby the objective sphingolipid represented by the formula [R<4a> is C(CO)R<8a> (R<8a> is a 13-23C alkyl, a 13-23C (poly)alkenyl) is simply obtained.
申请公布号 JPH1033193(A) 申请公布日期 1998.02.10
申请号 JP19970095311 申请日期 1997.03.28
申请人 ROHM & HAAS CO;US GOVERNMENT 发明人 MOREAU ROBERT ARTHUR;YOUNG DAVID HAMILTON;ROSS RONALD JR
分类号 C12P13/00;A01N33/08;A01N37/20;A01N49/00;A01N57/12;A61K31/66;A61K45/00;A61P3/08;A61P3/10;A61P29/00;A61P35/00;A61P43/00;C07F9/09;C07F9/113;C12P13/02;C12R1/645;(IPC1-7):C12P13/00 主分类号 C12P13/00
代理机构 代理人
主权项
地址